Home IMO

IMO

In operation
Series PreA
AI Large Molecule Drug Designer
Basic
Enterprise Profile

Basic Information

IMO is an AI large molecule drug design service provider. The company's mission is to leverage generative artificial intelligence technology to develop innovative drug screening algorithms, aiming to address the issues of long protein drug screening times and low accuracy.
Intelligent Medicine Original
Shanghai,China
15~50 people
November 27, 2023
7007502@qq.com

Enterprise Profile

Industrial Sector
New Drug Development CRO
Technology
Artificial Intelligence Protein Technology
Concept
Immune System Diseases Metabolic Diseases # Nervous System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs AI+Pharmaceuticals